The retinoblastoma tumor suppressor regulates a xenobiotic detoxification pathway

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Sáenz Robles, Maria Teresa ^a   Case, Ashley ^a,d   Chong, Jean Leon ^b,c   Leone, Gustavo ^b,c   Pipas, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG; RETINOBLASTOMA PROTEIN; TOXIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F3; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL POPULATION; CONTROLLED STUDY; DETOXIFICATION; DRUG DESIGN; DRUG METABOLISM; EMBRYO; FEMALE; GENE EXPRESSION; GENE MUTATION; MALE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MOUSE; NEOPLASM; NONHUMAN; TUMOR; TUMOR SUPPRESSOR GENE; XENOBIOTIC METABOLISM;

ANIMALS; ANIMALS, NEWBORN; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; LIVER; METABOLIC DETOXICATION, DRUG; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, KNOCKOUT; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TRANSCRIPTION, GENETIC; XENOBIOTICS;

MURINAE; MUS;

EID: 80053943695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026019     Document Type: Article

References (26)

1. Nassar AF, Hollenberg PF, Scatina J, (2009) Drug metabolism handbook: concepts and applications. Hoboken, N.J. Wiley. xvi, pp. 1041.
2. Nevins JR, Leone G, DeGregori J, Jakoi L, (1997) Role of the Rb/E2F pathway in cell growth control. J Cell Physiol 173: 233-236.
3. Chen HZ, Tsai SY, Leone G, (2009) Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 9: 785-797.
4. Chong JL, Wenzel PL, Saenz-Robles MT, Nair V, Ferrey A, et al. (2009) E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462: 930-934.
5. Saenz-Robles MT, Sullivan CS, Pipas JM, (2001) Transforming functions of Simian Virus 40. Oncogene 20: 7899-7907.
6. Ahuja D, Saenz-Robles MT, Pipas JM, (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24: 7729-7745.
7. Saenz Robles MT, Pipas JM, (2009) T antigen transgenic mouse models. Semin Cancer Biol 19: 229-235.
8. Saenz-Robles MT, Toma D, Cantalupo P, Zhou J, Gong H, et al. (2007) Repression of intestinal drug metabolizing enzymes by the SV40 large T antigen. Oncogene 26: 5124-5131.
9. Guengerich FP, (1991) Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266: 10019-10022.
10. Scripture CD, Sparreboom A, Figg WD, (2005) Modulation of cytochrome P450 activity: implications for cancer therapy. Lancet Oncol 6: 780-789.
11. Nelson DR, (2009) The cytochrome p450 homepage. Hum Genomics 4: 59-65.
12. Jancova P, Anzenbacher P, Anzenbacherova E, (2010) Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154: 103-116.
13. Gu X, Manautou JE, (2010) Regulation of hepatic ABCC transporters by xenobiotics and in disease states. Drug Metab Rev 42: 482-538.
14. Nevins JR, (2001) The Rb/E2F pathway and cancer. Hum Mol Genet 10: 699-703.
15. Harbour JW, Dean DC, (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409.
16. Nevins JR, (1992) Transcriptional regulation. A closer look at E2F. Nature 358: 375-376.
17. DeCaprio JA, (2009) How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. Virology 384: 274-284.
18. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, et al. (1992) Effects of an Rb mutation in the mouse. Nature 359: 295-300.
19. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, et al. (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
20. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, et al. (1992) Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
21. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, et al. (2003) Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421: 942-947.
22. Reed CA, Mayhew CN, McClendon AK, Yang X, Witkiewicz A, et al. (2009) RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1. Oncogene 28: 4434-4443.
23. Bosco EE, Knudsen ES, (2007) RB in breast cancer: at the crossroads of tumorigenesis and treatment. Cell Cycle 6: 667-671.
24. Stengel KR, Dean JL, Seeley SL, Mayhew CN, Knudsen ES, (2008) RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents. Cell Cycle 7: 1095-1103.
25. de Bruin A, Wu L, Saavedra HI, Wilson P, Yang Y, et al. (2003) Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc Natl Acad Sci U S A 100: 6546-6551.
26. Markovics JA, Carroll PA, Robles MT, Pope H, Coopersmith CM, et al. (2005) Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53. J Virol 79: 7492-7502.